Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 1.00 |
| ▸ | PGK2 | P07205 | 1/20 | 1.00 |
| ▸ | PGD | P52209 | 3/20 | 0.63 |
| ▸ | MPI | P34949 | 1/20 | 0.47 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.39 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.39 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Phosphoglyceric Acid SCHEMBL30428419 | 1.00 | PGK1 (1.00) | PGK1PGK2PGDMPIOR51E2 | |
| 3-Phosphoglyceric Acid SCHEMBL27483 | 1.00 | PGK1 (1.00) | PGK1PGK2PGDMPIOR51E2 | |
| 3-Phosphoglyceric Acid SCHEMBL2497743 | 1.00 | PGK1 (1.00) | PGK1PGK2PGDMPIOR51E2 | |
| 3-Phosphoglyceric Acid SCHEMBL8006738 | 0.90 | PGK1 (0.81) | PGK1PGK2PGDMPISMN1; SMN2 | |
| SCHEMBL1812894 | 0.83 | PGK1 (0.70) | PGK1PGK2PGDLPAR1LPAR3 | |
| SCHEMBL21724798 | 0.82 | PGK1 (0.69) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL2510085 | 0.82 | PGK1 (0.69) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL29357297 | 0.81 | PGK1 (0.68) | PGK1PGK2PGDMPILPAR5 | |
| 3-Phosphoglyceric Acid SCHEMBL15019970 | 0.80 | PGK1 (0.64) | PGK1PGK2PGD | |
| SCHEMBL704407 | 0.79 | PGK1 (0.65) | PGK1PGK2PGDMPILPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9905 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122074090-A | Diversified phage synthesis and engineering platform | 修兰教育基金管理公司 | 2026-05-22 | — | — | CN | claimed |
| WO-2026099434-A2 | EAMA TRANSPORTER MUTANTS AND USES THEREOF | CYSBIO APS (DK) | 2026-05-15 | — | — | WO | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20260063623-A1 | METHODS OF ASSESSING METABOLIC FLUX | UNIV MICHIGAN REGENTS (US) | 2026-03-05 | — | — | US | claimed |
| US-20260048146-A1 | METHODS AND COMPOSITIONS FOR TREATING LEUKODYSTROPHIES | BRIDGEBIO GENE THERAPY LLC (US) | 2026-02-19 | — | — | US | claimed |
| US-20260035705-A1 | ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | AGAIN BIO APS (DK) | 2026-02-05 | — | — | US | claimed |
| EP-4649314-A2 | POLYOL SWEETENERS AND CARDIOVASCULAR AND THROMBOTIC EVENT RISK | The Cleveland Clinic Foundation (US) | 2025-11-19 | — | — | EP | claimed |
| US-20250333686-A1 | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF GLYCERIC ACID AND DOWNSTREAM PRODUCTS | LYGOS, INC. (US) | 2025-10-30 | — | — | US | claimed |
| EP-4634372-A1 | METHOD FOR PRODUCING HYPOTAURINE BY FERMENTATION | Wacker Chemie AG (DE) | 2025-10-22 | — | — | EP | claimed |
| WO-1994024292-A9 | TRANSGENIC ORGANISM | — | 1994-12-08 | — | — | WO | claimed |
| WO-1994024292-A2 | TRANSGENIC ORGANISM | DANISCO A/S (DK) | 1994-10-27 | — | — | WO | claimed |
| EP-0620853-A1 | MATERIALS AND METHODS FOR BIOSYNTHESIS OF SERINE AND SERINE-RELATED PRODUCTS. | WACKER CHEMIE GMBH (DE) | 1994-10-26 | — | — | EP | claimed |
| WO-1994003815-A1 | TREATMENT OF BLOOD SAMPLES | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1994-02-17 | — | — | WO | claimed |
| WO-1993012235-A1 | MATERIALS AND METHODS FOR BIOSYNTHESIS OF SERINE AND SERINE-RELATED PRODUCTS | WACKER-CHEMIE GMBH (DE) | 1993-06-24 | — | — | WO | claimed |
| EP-0300008-A1 | DEVICE FOR DETERMINING PARAMETERS OF INTEREST IN LIVING ORGANISMS. | AVL AG (CH) | 1989-01-25 | — | — | EP | claimed |
| CN-1030352-A | Measure the method and apparatus of parameters of interest in the live organism | AVL AG (CH) | 1989-01-18 | — | — | CN | claimed |
| WO-1988005643-A1 | PROCESS AND DEVICE FOR DETERMINING PARAMETERS OF INTEREST IN LIVING ORGANISMS | AVL AG (CH) | 1988-08-11 | — | — | WO | claimed |
| EP-0260137-A2 | Assay method using novel NAD synthetase and a process for production of the enzyme | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1988-03-16 | — | — | EP | claimed |
| CN-86102858-A | The reorganization surface antigen of preparation porcine mycoplasmal and the method for vaccine thereof | — | 1987-10-28 | — | — | CN | claimed |